Mortality in Patients with Leukemia and Lymphoma Urgently Admitted to the PICU: Secondary Analysis of Data from a Cluster Randomized Controlled Trial

J Pediatr Intensive Care
DOI: 10.1055/s-0044-1778724

Sarah Nostedt

1   Division of Pediatric Critical Care, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada

,

Ruchi Sinha

2   Pediatric Critical Care, Imperial College Healthcare NHS Trust, London, United Kingdom

,

1   Division of Pediatric Critical Care, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada

,

Leah Szadkowski

3   Biostatistics Research Unit, Toronto General Hospital, Toronto, Ontario, Canada

,

Catherine Farrell

4   Pediatric Critical Care, CHU Sainte-Justine, Montreal, Quebec, Canada

,

Chris Parshuram

5   Department of Critical Care Medicine, Hospital for Sick Children, Toronto, Ontario, Canada

6   Child Health Evaluative Sciences Program and Center for Safety Research. SickKids Research Institute, Toronto, Ontario, Canada

7   Interdepartmental Division of Critical Care, Department of Pediatrics and Institute of Medical Science, Institute of Health Policy Management and Evaluation, Centre for Quality Improvement and Patient Safety, University of Toronto, Toronto, ON, Canada

› Author Affiliations Funding This work was in part funded by an unrestricted grant from the Gluskin Sheff and Associates Pediatric Critical Care Research Endowment. The funding agency had no role in the design, conduct, interpretation, or decision to publish this work.
› Further Information Also available at   SFX Search  Permissions and Reprints Abstract

Objectives were to describe the severity of illness in patients with leukemia or lymphoma urgently admitted to pediatric intensive care and explores the risk factors for mortality. A secondary analysis was performed of prospectively collected data from a cluster-randomized controlled trial in 21 children's hospitals from 2011 to 2015. Eligible patients were urgently admitted to intensive care and had a diagnosis of leukemia or lymphoma. Associations with intensive care mortality (primary outcome) were determined with multivariable generalized estimating equation with a logit link, accounting for clustering by site. Associations with time to intensive care mortality (secondary outcome) were determined with multivariable proportional hazards models. A total of 109 patients were included, age 115 (interquartile range [IQR] 42, 168) months and intensive care length of stay was 3 (IQR 2, 6) days. During the first hour in intensive care 36 (33%) were ventilated, and during intensive care 45 (41.3%) had at least 1 technology day. Day 1 Pediatric Logistic Organ Dysfunction (PELOD) score was ≥ 20 in 37 (33.9%), Pediatric Index of Mortality 2 mortality risk was > 10% in 35 (32.1%), and Children's Resuscitation Intensity Scale (RISC) was ≥ 3 (late admission to intensive care) in 32 (31.7%). Intensive care mortality was 20/109 (18.3%); with intensive care stay ≥ 20 days mortality was 51%. Previous urgent pediatric intensive care unit (PICU) admission, mechanical ventilation, and day 1 PELOD score were associated with higher PICU mortality. Mechanical ventilation, day 1 PELOD score, and late admission to the PICU (RISC ≥ 2) were associated with time to death. Patients with leukemia and lymphoma urgently admitted to intensive care had mortality of 18.3%, an improvement from historical cohorts. Risk factors were not accurate enough to make individual patient care decisions.

Keywords pediatric critical care - pediatric intensive care - leukemia - lymphoma - mortality - oncology Publication History

Received: 10 July 2023

Accepted: 20 December 2023

Article published online:
01 March 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
References 1 Wösten-van Asperen RM, van Gestel JPJ, van Grotel M. et al; POKER (PICU Oncology Kids in Europe Research group) research consortium. PICU mortality of children with cancer admitted to pediatric intensive care unit a systematic review and meta-analysis. Crit Rev Oncol Hematol 2019; 142: 153-163 2 Zinter MS, DuBois SG, Spicer A, Matthay K, Sapru A. Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit. Intensive Care Med 2014; 40 (10) 1536-1544 3 Rosenman MB, Vik T, Hui SL, Breitfeld PP. Hospital resource utilization in childhood cancer. J Pediatr Hematol Oncol 2005; 27 (06) 295-300 4 Heneghan JA, Pollack MM. Morbidity: changing the outcome paradigm for pediatric critical care. Pediatr Clin North Am 2017; 64 (05) 1147-1165 5 Parshuram CS, Dryden-Palmer K, Farrell C. et al; Canadian Critical Care Trials Group and the EPOCH Investigators. Effect of a Pediatric Early Warning System on all-cause mortality in hospitalized pediatric patients: the EPOCH randomized clinical trial. JAMA 2018; 319 (10) 1002-1012 6 Leteurtre S, Martinot A, Duhamel A. et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 2003; 362 (9379): 192-197 7 Slater A, Shann F, Pearson G. Paediatric Index of Mortality (PIM) Study Group. PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 2003; 29 (02) 278-285 8 Parshuram CS, Dryden-Palmer K, Farrell C. et al; Canadian Critical Care Trials Group. Evaluating processes of care and outcomes of children in hospital (EPOCH): study protocol for a randomized controlled trial. Trials 2015; 16: 245 9 Faraci M, Bagnasco F, Giardino S. et al. Intensive care unit admission in children with malignant or nonmalignant disease: incidence, outcome, and prognostic factors: a single-center experience. J Pediatr Hematol Oncol 2014; 36 (07) e403-e409 10 Rr P, Tan EEK, Sultana R. et al. Critical illness epidemiology and mortality risk in pediatric oncology. Pediatr Blood Cancer 2020; 67 (06) e28242 11 Caballero M, Faura A, Margarit A. et al. Outcomes for paediatric acute leukaemia patients admitted to the paediatric intensive care unit. Eur J Pediatr 2022; 181 (03) 1037-1045 12 Dalton HJ, Slonim AD, Pollack MM. MultiCenter outcome of pediatric oncology patients requiring intensive care. Pediatr Hematol Oncol 2003; 20 (08) 643-649 13 Tamburro RF, Barfield RC, Shaffer ML. et al. Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation. Pediatr Crit Care Med 2008; 9 (03) 270-277 14 Hallahan AR, Shaw PJ, Rowell G, O'Connell A, Schell D, Gillis J. Improved outcomes of children with malignancy admitted to a pediatric intensive care unit. Crit Care Med 2000; 28 (11) 3718-3721 15 Shimabukuro-Vornhagen A, Böll B, Kochanek M, Azoulay É, von Bergwelt-Baildon MS. Critical care of patients with cancer. CA Cancer J Clin 2016; 66 (06) 496-517 16 Rogerson CM, Rowan CM. Critical care utilization in children with cancer: U.S. Pediatric Health Information System Database cohort 2012–2021. Pediatr Crit Care Med 2024; 25 (01) e52-e58 17 Meyer S, Gottschling S, Biran T. et al. Assessing the risk of mortality in paediatric cancer patients admitted to the paediatric intensive care unit: a novel risk score?. Eur J Pediatr 2005; 164 (09) 563-567 18 Ranta S, Broman LM, Abrahamsson J. et al. ICU admission in children with acute lymphoblastic leukemia in Sweden: Prevalence, outcome, and risk factors. Pediatr Crit Care Med 2021; 22 (12) 1050-1060
 

Comments (0)

No login
gif